1. Anti-androgen for myoepithelial tumor: a potent therapy yet a potential misleader. Issue 1 (January 2022) Authors: Hijab, Adham; Taha, Tarek; Charas, Tomer; Bar-Sela, Gil; Stein, Polina; Agbarya, Abed Journal: Anti-cancer drugs Issue: Volume 33:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of daily soft‐tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT. Issue 7 (17th June 2019) Authors: Tyagi, Neelam; Hipp, Elizabeth; Cloutier, Michelle; Charas, Tomer; Fontenla, Sandra; Mechalakos, James; Hunt, Margie; Zelefsky, Michael Journal: Journal of applied clinical medical physics Issue: Volume 20:Issue 7(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Second malignancy risk in prostate cancer and radiotherapy. (February 2017) Authors: Charas, Tomer; Taggar, Amandeep; Zelefsky, Michael J Journal: Future oncology Issue: Volume 13:Number 5(2017) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗